Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 7;20(5):1165-79.
doi: 10.3748/wjg.v20.i5.1165.

Intestinal barrier in inflammatory bowel disease

Lena Antoni  1 , Sabine Nuding  1 , Jan Wehkamp  1 , Eduard F Stange  1
Affiliations
Review

Intestinal barrier in inflammatory bowel disease

Lena Antoni et al. World J Gastroenterol. .

Abstract

A complex mucosal barrier protects as the first line of defense the surface of the healthy intestinal tract from adhesion and invasion by luminal microorganisms. In this review, we provide an overview about the major components of this protective system as for example an intact epithelium, the synthesis of various antimicrobial peptides (AMPs) and the formation of the mucus layer. We highlight the crucial importance of their correct functioning for the maintenance of a proper intestinal function and the prevention of dysbiosis and disease. Barrier disturbances including a defective production of AMPs, alterations in thickness or composition of the intestinal mucus layer, alterations of pattern-recognition receptors, defects in the process of autophagy as well as unresolved endoplasmic reticulum stress result in an inadequate host protection and are thought to play a crucial role in the pathogenesis of the inflammatory bowel diseases Crohn's disease and ulcerative colitis.

Keywords: Antimicrobial peptide; Crohn’s disease; Goblet cell; Inflammatory bowel disease; Intestinal barrier; Mucus layer; Paneth cell; Ulcerative colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Defense mechanisms of the healthy intestinal mucosal barrier.
Figure 2
Figure 2
Defects of the intestinal mucosal barrier in inflammatory bowel disease and their consequences. IBD: Inflammatory bowel disease; CD: Crohn’s disease; UC: Ulcerative colitis.
See this image and copyright information in PMC

References

    1. Wehkamp J, Stange EF. Paneth’s disease. J Crohns Colitis. 2010;4:523–531. - PubMed
    1. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4607–4614. - PMC - PubMed
    1. Goto Y, Kiyono H. Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol Rev. 2012;245:147–163. - PubMed
    1. Hindryckx P, Laukens D. Intestinal barrier dysfunction: The primary driver of IBD? Inflammatory Bowel Disease -Advances in Pathogenesis and Management, Dr. Sami Karoui (Ed.), 2012; ISBN: 978-953-307-891-5, InTech. Available from: http://www.intechopen.com/download/pdf/268396.
    1. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594. - PubMed

Publication types